Literature DB >> 32285320

Transjugular Intrahepatic Porto Systemic Shunt for Hepatorenal Syndrome in Alcoholic Patients.

Gianni Testino1.   

Abstract

Entities:  

Year:  2020        PMID： 32285320     DOI： 10.1007/s10620-020-06243-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  5 in total

1.  Type-1 hepatorenal syndrome in patients with alcoholic end stage liver disease listed for liver transplantation: role of transjugular intrahepatic portosystemic stent shunt.

Authors:  G Testino; C Ferro
Journal:  Panminerva Med       Date:  2007-03       Impact factor: 5.197

2.  Inpatient Mortality Benefit with Transjugular Intrahepatic Portosystemic Shunt for Hospitalized Hepatorenal Syndrome Patients.

Authors:  Paris Charilaou; Kalpit Devani; Romela Petrosyan; Chakradhar Reddy; Nikolaos Pyrsopoulos
Journal:  Dig Dis Sci       Date:  2020-02-15       Impact factor: 3.199

3.  Management of end-stage alcohol-related liver disease and severe acute alcohol-related hepatitis: position paper of the Italian Society on Alcohol (SIA).

Authors:  Gianni Testino; Teo Vignoli; Valentino Patussi; Emanuele Scafato; Fabio Caputo
Journal:  Dig Liver Dis       Date:  2019-11-19       Impact factor: 4.088

4.  Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.

Authors:  Gianni Testino; Carlo Ferro; Alessandro Sumberaz; Piergiorgio Messa; Nicola Morelli; Barbara Guadagni; Giorgio Ardizzone; Umberto Valente
Journal:  Hepatogastroenterology       Date:  2003 Nov-Dec

5.  Severe acute alcoholic hepatitis and hepatorenal syndrome: role of transjugular intrahepatic portosystemic stent shunt.

Authors:  G Testino; S Leone; C Ferro; P Borro
Journal:  J Med Life       Date:  2012-06-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.